Direct-to-Consumer Genetic Testing: Worthwhile or Risky? Direct-to-Consumer (DTC) genetic testing companies market genetic tests directly to the public and often claim that testing is for entertainment purposes only. 
However, some information gained from DTC testing may significantly impact medical care. This talk will address some of the controversy around DTC testing and whether results of such testing are clinically accurate and allow us to engage with this very pertinent topic with a help of an expert in the field, Rachel E. Barnett.
Rachel E. Barnett, MS is a Senior Genetic Counselor specializing in cancer genetics at the Yale Cancer Center, Yale School of Medicine. She earned her Master of Science at the University of North Carolina Greensboro, is board certified by the American Board of Genetic Counseling, and joined Yale in 2004. She has provided lectures to many professional and public groups in Connecticut and is an author on several articles about hereditary cancer syndromes.
Bagels and coffee at 9:45 AM; talk and Q&A from 10:00 AM until 11:45 AM.